Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -174.27x is 181% below its 5-year average of -62.04x, around the middle of its 5-year range (-423.57x–-11.28x).
As of the fiscal period ended Saturday, December 31, 2022.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2022 (2022-12-31): -174.27x.
INTEREST COVERAGE RATIO
-174.27x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-246.43x
INTEREST COVERAGE RATIO AVG 5Y
-62.04x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+29.28%
CURRENT VS 5Y AVG
-180.89%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-2633.58%
vs the sector median at left
XORTX Therapeutics Inc.
Market Cap
$481786.00
Interest Coverage Ratio
-174.27x
TTM Avg
N/A
3Y Avg
-246.43x
5Y Avg
-62.04x
Market Cap
$518606.00
Interest Coverage Ratio
-935.33x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$556226.00
Interest Coverage Ratio
-9.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$385197.00
Interest Coverage Ratio
-18.99x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$378849.00
Interest Coverage Ratio
-103.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$656789.00
Interest Coverage Ratio
-113.13x
TTM Avg
1218.67x
3Y Avg
620.28x
5Y Avg
620.28x
Market Cap
$252756.00
Interest Coverage Ratio
-795.36x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$716854.00
Interest Coverage Ratio
-115.23x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$824550.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| XORTX Therapeutics Inc. (XRTX) | $481786.00 | -174.27x | N/A | -246.43x | -62.04x |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | -935.33x | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB)vs › | $556226.00 | -9.00x | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $385197.00 | -18.99x | N/A | N/A | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | -103.60x | N/A | N/A | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $656789.00 | -113.13x | 1218.67x | 620.28x | 620.28x |
| SciSparc Ltd. (SPRC)vs › | $252756.00 | -795.36x | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $716854.00 | -115.23x | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $824550.00 | N/A | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $827875.00 | -8287.21x | N/A | N/A | N/A |
Interest Coverage
-174.3x
Debt/Equity
0.00
Current Ratio
3.59
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-12-31 | -174.27x |
| 2021-09-30 | -375.82x |
| 2020-12-31 | -423.57x |
| 2019-12-31 | -12.07x |
| 2019-09-30 | -40.80x |
| 2019-06-30 | -23.27x |
| 2019-03-31 | -23.41x |
| 2018-12-31 | -11.28x |
| 2018-09-30 | -87.75x |
| 2018-06-30 | -37.44x |
| 2018-03-31 | -160.28x |
| 2017-12-31 | -49.84x |
| 2017-09-30 | -24.09x |
| 2017-05-31 | -8.09x |
| 2017-02-28 | -31.71x |
